Segment Reporting (Segments Statements of Operations) (Details) (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Segment Reporting Information [Line Items]
Product revenue	$ 24,446,525	$ 25,575,276
Revenues, net	24,446,525	25,575,276
Cost of goods sold	15,175,706	17,250,273
Marketing, general and administrative	10,024,089	10,678,655
Research and development	1,480,769	1,602,616
Goodwill Impairment	0	905,810
Total costs and expenses	26,680,564	30,437,354
Loss from operations	(2,234,039)	(4,862,078)
Loss (gain) on sales of assets	(86,885)	0
Equity in OTM	7,491	(70,393)
Interest income	137	240
Interest Expense	(344,243)	(323,611)
Total other (expense) income	(423,500)	(393,764)
(Loss) and income before taxes	(2,657,539)	(5,255,842)
Income taxes benefit from continuing operations	0	(239,879)
Net (loss) from continuing operations	(2,657,539)	(5,015,963)
Escalon Clinical Diagnostics [Member]
Segment Reporting Information [Line Items]
Product revenue	12,984,994	13,708,507
Revenues, net	12,984,994	13,708,507
Cost of goods sold	9,416,085	10,775,118
Marketing, general and administrative	5,297,012	6,124,391
Research and development	476,210	725,418
Goodwill Impairment	0	0
Total costs and expenses	15,189,307	17,624,927
Loss from operations	(2,204,313)	(3,916,420)
Loss (gain) on sales of assets	(86,885)	0
Equity in OTM	0	0
Interest income	127	0
Interest Expense	(165,902)	(323,611)
Total other (expense) income	(252,660)	(323,611)
(Loss) and income before taxes	(2,456,973)	(4,240,031)
Income taxes benefit from continuing operations	0	0
Net (loss) from continuing operations	(2,456,973)	(4,240,031)
Sonomed-Escalon [Member]
Segment Reporting Information [Line Items]
Product revenue	11,461,531	11,866,769
Revenues, net	11,462,000	11,867,000
Cost of goods sold	5,759,621	6,475,155
Marketing, general and administrative	4,226,196	3,701,721
Research and development	1,004,559	877,198
Goodwill Impairment	0	905,810
Total costs and expenses	10,991,000	11,960,000
Loss from operations	471,000	(93,000)
Loss (gain) on sales of assets	0	0
Equity in OTM	0	0
Interest income	0	0
Interest Expense	0	0
Total other (expense) income	0	0
(Loss) and income before taxes	471,000	(93,000)
Income taxes benefit from continuing operations	0	0
Net (loss) from continuing operations	471,000	(93,000)
Corporate [Member]
Segment Reporting Information [Line Items]
Product revenue	0	0
Revenues, net	0	0
Cost of goods sold	0	0
Marketing, general and administrative	500,881	852,543
Research and development	0	0
Goodwill Impairment	0	0
Total costs and expenses	501,000	853,000
Loss from operations	(501,000)	(853,000)
Loss (gain) on sales of assets	0	0
Equity in OTM	7,491	(70,393)
Interest income	10	240
Interest Expense	(178,341)	0
Total other (expense) income	(171,000)	(70,000)
(Loss) and income before taxes	(672,000)	(923,000)
Income taxes benefit from continuing operations	0	(239,879)
Net (loss) from continuing operations	$ (672,000)	$ (683,000)